Biotech and Pharmaceuticals


  • Obama seeks $215 million for 'precision medicine' Friday, 30 Jan 2015 | 6:00 AM ET
    President Barack Obama delivers the State of the Union address on January 20, 2015 in the House Chamber of the U.S. Capitol in Washington.

    President Obama will dedicate $215 million in his budget request to a program that will target the underlying cause of disease.

  • LLY's quarterly checkup: CEO  Friday, 30 Jan 2015 | 7:15 AM ET

    John Lechleiter, Eli Lilly CEO, runs through the quarterly numbers and provides insight to products coming off patents, R&D, and new Alzheimer's drugs in the pipeline.

  • Reinventing pharma's next big frontier: Pro  Friday, 30 Jan 2015 | 7:05 AM ET

    Fred Hassan, Warburg Pincus Partner, talks about the way information technology is changing the face of modern medicine and transforming the health care industry.

  • White House targets precision medicine  Friday, 30 Jan 2015 | 7:03 AM ET

    CNBC's Meg Tirrell has details on the meeting today between President Obama and drugmakers to discuss how to improve health and treat disease.

  • Biogen reports higher-than-expected Q4 profit Thursday, 29 Jan 2015 | 5:17 PM ET
    A multiple sclerosis drug manufactured at the Biogen Idec manufacturing plant in Cambridge, Mass.

    Biogen on Thursday reported higher-than-expected fourth-quarter profit on strong demand for its oral multiple sclerosis drug Tecfidera.

  • Battle against baldness turns to stem cells Thursday, 29 Jan 2015 | 4:46 PM ET

    Two new studies discuss turning stem cells into hair cells and transplanting them onto bald spots.

  • When does the biotech party end? Thursday, 29 Jan 2015 | 2:27 PM ET

    The sheer volume and pace of biotech offerings are causing some to question whether the sector is nearing the end of its years of buoyancy.

  • Researchers could have cure for peanut allergies Thursday, 29 Jan 2015 | 12:59 PM ET

    Researchers found that feeding a group of children a form of beneficial bacteria helped them overcome a potentially fatal food allergy.

  • 2015's strong outlook for healthcare IPOs  Thursday, 29 Jan 2015 | 5:40 AM ET

    Cathrin Petty, co-head of EMEA healthcare at JP Morgan, says the U.K. has the capacity to be a successful market for life sciences, and the year ahead for healthcare IPOs looks strong.

  • The rise and rise of life sciences  Thursday, 29 Jan 2015 | 4:55 AM ET

    George Freeman MP, minister of life sciences in the U.K., says there's been a "resurgence" for life sciences and healthcare investment.

  • Cracking down on cat allergies  Thursday, 29 Jan 2015 | 4:30 AM ET

    Steve Harris, CEO of Circassia, says his company is combating allergies by tackling how they affect people's immune systems, rather than simply making products that provide "symptomatic relief".

  • Drugmakers get mysterious invites to White House Wednesday, 28 Jan 2015 | 5:06 PM ET
    President Barack Obama

    The heads of research at several large drugmakers have received mysterious invitations to the White House for a meeting Friday morning.

  • Amgen profit tops expectations Tuesday, 27 Jan 2015 | 5:04 PM ET
    Amgen building in South San Francisco, California.

    Amgen on Tuesday reported higher-than-expected fourth-quarter profit.

  • Bristol-Myers quarterly profit beats forecasts Tuesday, 27 Jan 2015 | 9:22 AM ET
    Bristol-Myers Squibb R&D headquarters.

    Bristol-Myers Squibb reported higher-than-expected earnings, helped by strong sales of its hepatitis C drugs and its Eliquis blood clot preventer.

  • Pfizer's 2015 forecast disappoints, hit by dollar Tuesday, 27 Jan 2015 | 7:36 AM ET

    Pfizer reported stronger-than-expected quarterly results as sales of vaccines and cancer drugs increased.

  • Impact of a strong U.S. dollar  Tuesday, 27 Jan 2015 | 5:50 AM ET

    Cole Smead, portfolio manager at Smead Capital Management, discusses the strong U.S. dollar and how it will affect sectors like pharmaceuticals.

  • Novartis flags faster sales, profit growth for 2015 Tuesday, 27 Jan 2015 | 2:48 AM ET
    Joe Jimenez, CEO of Novartis, at 2015 WEF in Davos, Switzerland.

    Novartis forecast sales and profits to grow at a faster pace this year driven by recent drug successes and its portfolio overhaul.

  • First case of H7N9 bird flu found in North America Monday, 26 Jan 2015 | 5:18 PM ET
    A technician deals with test reagents for bird flu virus

    Canadian health authorities say they have diagnosed the first case of bird flu in a British Columbia woman who recently returned from China.

  • Bird flu detected at California turkey farm Monday, 26 Jan 2015 | 12:45 PM ET

    A California turkey farm has been quarantined after confirmation of an outbreak of the highly pathogenic H5N8 avian influenza strain.

  • Scientists unboil an egg, and it may be a big deal Friday, 23 Jan 2015 | 4:13 PM ET

    The ability to unfold a protein and return it to its original state could save money in everything from cancer research to food production.

Contact Biotech and Pharma


    Get the best of CNBC in your inbox

    To learn more about how we use your information,
    please read our Privacy Policy.
    › Learn More


  • Dan Mangan is a reporter covering health care for CNBC.com.

  • Meg Tirrell joined CNBC in April 2014 as a general assignment reporter focusing on biotechnology and pharmaceuticals.

  • Bertha Coombs is a general assignment reporter for CNBC, covering financial markets and business news stories.